234 related articles for article (PubMed ID: 29727605)
1. The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review.
van de Peppel RJ; Visser LG; Dekkers OM; de Boer MGJ
J Infect; 2018 Jun; 76(6):550-562. PubMed ID: 29727605
[TBL] [Abstract][Full Text] [Related]
2. Invasive Aspergillosis among Haematological Malignancy Patients in Ghana: A Pilot Study on Prevalence and Antifungal Prophylaxis at the National Referral Hospital.
Ocansey BK; Otoo B; Gbadamosi H; Opintan JA; Dei-Adomakoh Y; Kosmidis C; Denning DW
West Afr J Med; 2023 Jun; 40(6):613-618. PubMed ID: 37390225
[TBL] [Abstract][Full Text] [Related]
3. Invasive aspergillosis in children with hematological malignancies.
Ozen M; Dündar NO
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):299-306. PubMed ID: 21417869
[TBL] [Abstract][Full Text] [Related]
4. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of epidemiology, risk factors, diagnosis, antifungal resistance, and management of invasive aspergillosis in Africa.
Yerbanga IW; Nakanabo Diallo S; Rouamba T; Denis O; Rodriguez-Villalobos H; Montesinos I; Bamba S
J Mycol Med; 2023 Mar; 33(1):101328. PubMed ID: 36265260
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
Le Clech L; Uguen M; Quinio D; Nevez G; Couturier MA; Ianotto JC; Berthou C; Guillerm G; Le Bars H; Payan C; Narbonne V; Baron R; Saliou P
Curr Res Transl Med; 2020 Jan; 68(1):23-28. PubMed ID: 31787568
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Invasive Aspergillosis: a Retrospective Review of 59 Cases.
Özen S; Özdemir H; Taşkin EÇ; Arga G; Konca HK; Çakmakli HF; Haskoloğlu Ş; Okulu E; Dinçaslan H; İnce E; İleri T; Taçyildiz N; Doğu F; Evren E; Us E; Karahan ZC; Fitöz S; Kendirli T; Kuloğlu Z; Tutar E; İkincioğullari A; Ünal E; Ertem M; İnce E; Çiftçi E
Jpn J Infect Dis; 2023 Mar; 76(2):113-119. PubMed ID: 36450573
[TBL] [Abstract][Full Text] [Related]
8. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study.
Mariette C; Tavernier E; Hocquet D; Huynh A; Isnard F; Legrand F; Lhéritier V; Raffoux E; Dombret H; Ifrah N; Cahn JY; Thiébaut A
Leuk Lymphoma; 2017 Mar; 58(3):586-593. PubMed ID: 27397551
[TBL] [Abstract][Full Text] [Related]
10. Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France.
Denis B; Guiguet M; de Castro N; Mechaï F; Revest M; Melica G; Costagliola D; Lortholary O;
Clin Infect Dis; 2015 Oct; 61(8):1273-80. PubMed ID: 26123932
[TBL] [Abstract][Full Text] [Related]
11. Invasive aspergillosis in a paediatric haematology department: a 15-year review.
Crassard N; Hadden H; Piens MA; Pondarré C; Hadden R; Galambrun C; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
Mycoses; 2008 Mar; 51(2):109-16. PubMed ID: 18254746
[TBL] [Abstract][Full Text] [Related]
12. Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study.
Park JH; Ryu SH; Lee JY; Kim HJ; Kwak SH; Jung J; Lee J; Sung H; Kim SH
Antimicrob Resist Infect Control; 2019; 8():88. PubMed ID: 31161035
[TBL] [Abstract][Full Text] [Related]
13. National trends in incidence, prevalence and disability-adjusted life years of invasive aspergillosis in Iran: a systematic review and meta-analysis.
Tavakoli M; Yazdani Charati J; Hedayati MT; Moosazadeh M; Badiee P; Seyedmousavi S; Denning DW
Expert Rev Respir Med; 2019 Nov; 13(11):1121-1134. PubMed ID: 31426666
[No Abstract] [Full Text] [Related]
14. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.
Akan H; Antia VP; Kouba M; Sinkó J; Tănase AD; Vrhovac R; Herbrecht R
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii5-16. PubMed ID: 24155144
[TBL] [Abstract][Full Text] [Related]
15. A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.
Leonart LP; Tonin FS; Ferreira VL; Penteado STS; Wiens A; Motta FA; Pontarolo R
J Clin Pharm Ther; 2017 Oct; 42(5):530-538. PubMed ID: 28620958
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
[TBL] [Abstract][Full Text] [Related]
17. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
18. 'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.
Del Principe MI; Dragonetti G; Verga L; Candoni A; Marchesi F; Cattaneo C; Delia M; Potenza L; Farina F; Ballanti S; Decembrino N; Castagnola C; Nadali G; Fanci R; Orciulo E; Veggia B; Offidani M; Melillo L; Manetta S; Tumbarello M; Venditti A; Busca A; Aversa F; Pagano L;
J Antimicrob Chemother; 2019 Apr; 74(4):1062-1068. PubMed ID: 30649413
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis for aspergillosis in patients with haematological malignancies: pros and cons.
Busca A; Pagano L
Expert Rev Anti Infect Ther; 2018 Jul; 16(7):531-542. PubMed ID: 30033822
[TBL] [Abstract][Full Text] [Related]
20. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II
J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
